학술논문

Pressure to respond: Hypertension predicts clinical benefit from bevacizumab in recurrent ovarian cancer
Document Type
Abstract
Source
In Gynecologic Oncology March 2011 120 Supplement 1:S37-S37
Subject
Language
ISSN
0090-8258